{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:15:43Z","timestamp":1768900543051,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Ibrutinib, a Bruton tyrosine kinase inhibitor, is widely used in chronic lymphocytic leukemia (CLL). Its association with secondary hemophagocytic lymphohistiocytosis (HLH) is exceedingly rare but potentially fatal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 59-year-old male with CLL presented with recurrent fever and progressive splenomegaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Bone marrow biopsy confirmed CLL. Five months after ibrutinib (420\u2009mg\/day) initiation, progressive pancytopenia, hyperferritinemia, and hemophagocytosis on repeat marrow aspirate established HLH diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>HLH-94 protocol (etoposide\u2005+\u2005dexamethasone) was initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient developed fungemia followed by massive cerebral infarction. Treatment was withdrawn due to deterioration, resulting in death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Ibrutinib may trigger HLH via immune dysregulation. Early recognition through vigilant monitoring of cytopenias, ferritin, and marrow hemophagocytosis is critical to improve survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045957","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:05Z","timestamp":1768849265000},"page":"e45957","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of hemophagocytic lymphohistiocytosis occurring during ibrutinib chemotherapy with a literature review"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1462-8098","authenticated-orcid":false,"given":"Xiaonan","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manzhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengchao","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-429X","authenticated-orcid":false,"given":"Yan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s12098-009-0219-6","article-title":"Invasive candidiasis in pediatric intensive care units.","volume":"76","author":"Singhi","year":"2009","journal-title":"Indian J Pediatr"},{"key":"R3-20260119","first-page":"39","article-title":"Risk factors analysis for deep fungal infection in patients with large area cerebral infarction [Chinese].","volume":"19","author":"Wang","year":"2016","journal-title":"Zhongguo Shi Yong Shen Jing Ji Bing Za Zhi"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/RMR.0000000000000025","article-title":"Magnetic resonance imaging in fungal infections of the brain.","volume":"23","author":"Palacios","year":"2014","journal-title":"Top Magn Reson Imaging"},{"key":"R5-20260119","first-page":"11","article-title":"Hemophagocytic lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed\/refractory chronic lymphocytic leukemia.","volume":"7","author":"Cavallari","year":"2017","journal-title":"Leuk Res Rep"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome.","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/INF.0b013e3181813592","article-title":"Clinical aspects, immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis.","volume":"28","author":"Lee","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities.","volume":"174","author":"Brisse","year":"2016","journal-title":"Br J Haematol"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"R243","DOI":"10.1186\/cc10501","article-title":"Early natural killer cell counts in blood predict mortality in severe sepsis.","volume":"15","author":"Andaluz-Ojeda","year":"2011","journal-title":"Crit Care"},{"key":"R10-20260119","first-page":"1779","article-title":"Interpretation of Chinese expert consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with lymphoma (2022) [Chinese].","volume":"102","author":"Wei","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management.","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.bbmt.2018.12.756","article-title":"Cytokine release syndrome with chimeric antigen receptor T cell therapy.","volume":"25","author":"Frey","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1182\/blood-2013-02-485623","article-title":"Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.","volume":"121","author":"Teachey","year":"2013","journal-title":"Blood"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2014-01-547869","article-title":"Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity.","volume":"123","author":"Kohrt","year":"2014","journal-title":"Blood"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.3390\/ijms26178683","article-title":"UNC13D c.2588G>A nucleotide variant impairs NK-cell cytotoxicity in adult-onset EBV-associated hemophagocytic lymphohistiocytosis: a pedigree study.","volume":"26","author":"Gu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"E296","DOI":"10.1002\/ajh.25611","article-title":"Ibrutinib-associated hemophagocytic lymphohistiocytosis: a case series from Johns Hopkins.","volume":"94","author":"Ambinder","year":"2019","journal-title":"Am J Hematol"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1080\/10428194.2016.1243679","article-title":"Rapid onset of hemophagocytic lymphohistiocytosis in a patient with refractory chronic lymphocytic leukemia treated with ibrutinib.","volume":"58","author":"Poole","year":"2017","journal-title":"Leuk Lymphoma"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:07Z","timestamp":1768849267000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045957","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2025-08-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}